Nintedanib in children and adolescents with fibrosing interstitial lung diseases.

Deterding R, Young LR, DeBoer EM, Warburton D, Cunningham S, Schwerk N, Flaherty KR, Brown KK, Dumistracel M, Erhardt E, Bertulis J, Gahlemann M, Stowasser S, Griese M, InPedILD trial investigators

Open source

DOI
10.1183/13993003.01512-2022
Published
2023 Feb
Container
The European respiratory journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1183/13993003.01512-2022,
  title = {Nintedanib in children and adolescents with fibrosing interstitial lung diseases.},
  author = {Deterding R and Young LR and DeBoer EM and Warburton D and Cunningham S and Schwerk N and Flaherty KR and Brown KK and Dumistracel M and Erhardt E and Bertulis J and Gahlemann M and Stowasser S and Griese M and InPedILD trial investigators},
  year = {2023},
  journal = {The European respiratory journal},
  doi = {10.1183/13993003.01512-2022},
  url = {https://doi.org/10.1183/13993003.01512-2022}
}

RIS

TY  - JOUR
TI  - Nintedanib in children and adolescents with fibrosing interstitial lung diseases.
AU  - Deterding R
AU  - Young LR
AU  - DeBoer EM
AU  - Warburton D
AU  - Cunningham S
AU  - Schwerk N
AU  - Flaherty KR
AU  - Brown KK
AU  - Dumistracel M
AU  - Erhardt E
AU  - Bertulis J
AU  - Gahlemann M
AU  - Stowasser S
AU  - Griese M
AU  - InPedILD trial investigators
PY  - 2023
JO  - The European respiratory journal
DO  - 10.1183/13993003.01512-2022
UR  - https://doi.org/10.1183/13993003.01512-2022
ER  - 

APA

R, D., LR, Y., EM, D., D, W., S, C., N, S., KR, F., KK, B., M, D., E, E., J, B., M, G., S, S., M, G., & investigators, I. T. (2023). Nintedanib in children and adolescents with fibrosing interstitial lung diseases.. The European respiratory journal. https://doi.org/10.1183/13993003.01512-2022

Source records